NEPH Share Price Performance
US$0
-4.27 (-100.00%)
Price US$0
Fair ValueUS$4.75
Share Pricen/a
Narrative Update • Aug 15
Nephros, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 11 Fair Values set on narratives written by author
NEPH Community Narratives
AN
Fair Value
·Fair Value US$4.75 4.8% undervalued intrinsic discount
Hospital Infection Control Challenges May Limit Near-Term Upside Yet Long-Term Potential Appears Intact
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value US$6 24.7% undervalued intrinsic discount
PFAS And Pathogen Regulations Will Support Long Term Upside Potential
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value US$8 43.5% undervalued intrinsic discount
PFAS And Water Safety Demand Will Drive Strong Long-Term Upside Potential
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Nephros
4.8% undervalued intrinsic discount
Hospital Infection Control Challenges May Limit Near-Term Upside Yet Long-Term Potential Appears Intact
View narrativeAN
Updated 15 Aug
Nephros
24.7% undervalued intrinsic discount
PFAS And Pathogen Regulations Will Support Long Term Upside Potential
View narrativeAN
Updated 1 Aug
Nephros
43.5% undervalued intrinsic discount
PFAS And Water Safety Demand Will Drive Strong Long-Term Upside Potential
View narrativeAN
Published 4 Jan
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
NEPH: Index Additions And M&A Options Will Shape Balanced Future Outlook
Fair Value: US$4.75 4.8% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
NEPH: Index Additions And Water Filtration Leadership Will Support Future Upside
Fair Value: US$6 24.7% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
PFAS And Water Safety Demand Will Drive Strong Long-Term Upside Potential
Fair Value: US$8 43.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Nephros, Inc. Key Details
About NEPH
- Founded
- 1997
- Employees
- 36
- CEO
- WebsiteView website
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
